Yahoo
    BSE - Delayed Quote INR

    Zydus Lifesciences Limited (ZYDUSLIFE.BO)

    1,244.00 +58.00 (+4.89%)
    At close: October 30 at 3:51:30 PM GMT+5:30
    ZYDUSLIFE.BO Q2 2027 earnings call
    November 4, 2026 at 3 PM GMT+5:30
    Loading Chart for ZYDUSLIFE.BO
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.

    Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
    CNW Group 27d ago
    Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.

    Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
    PR Newswire 27d ago
    Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

    Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA
    CNW Group 19d ago
    Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA

    Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA
    PR Newswire 19d ago
    Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across Geographic Subgroups in PBC

    Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across Geographic Subgroups in PBC
    PR Newswire 20d ago
    Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

    Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat
    Pharmaceutical Technology 2mo ago
    Zydus Lifesciences Ltd (BOM:532321) (Q1 2027) Earnings Call Highlights: Robust 66. ...

    Zydus Lifesciences Ltd (BOM:532321) (Q1 2027) Earnings Call Highlights: Robust 66. ...
    GuruFocus.com 2mo ago
    Zydus to acquire Assertio in $166m deal

    Zydus to acquire Assertio in $166m deal
    Pharmaceutical Technology 5mo ago
    Zydus Lifesciences Ltd (BOM:532321) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ...

    Zydus Lifesciences Ltd (BOM:532321) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ...
    GuruFocus.com 8mo ago
    LGND: New Year Program Updates

    LGND: New Year Program Updates
    Zacks Small Cap Research 8mo ago
    Agenus Webcast: Zydus Manufacturing Deal Closes, France Access Expands, Phase 3 BATMAN Nears Launch

    Agenus Webcast: Zydus Manufacturing Deal Closes, France Access Expands, Phase 3 BATMAN Nears Launch
    MarketBeat 8mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: